(Q61700384)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Pharmacokinetics and local safety profile of propranolol eye drops in rabbits (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Alessandro Pini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Cecilia Lanzi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Giancarlo la Marca

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Luca Filippi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Letizia Padrini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Benedetta Isacchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Emanuela Masini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Maria Luisa Della Bona

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Anna Maria Calvani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Riccardo Ceccantini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

16 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

378-385

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25029260%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/pr.2014.108

9 March 2020

exact match

0 references

cites work

Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Vascular endothelial growth factor in eye disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Propranolol for severe hemangiomas of infancy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Retinopathy of prematurity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Beta-adrenoreceptor agonism influences retinal responses to hypoxia in a model of retinopathy of prematurity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Effect of norepinephrine on RhoA, MAP kinase, proliferation and VEGF expression in human umbilical vein endothelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Norepinephrine upregulates vascular endothelial growth factor in rat cardiac myocytes by a paracrine mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Infantile hemangiomas and retinopathy of prematurity: possible association.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Propranolol concentrations after oral administration in term and preterm neonates.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Topical propranolol and ocular tension in the human

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

A pharmacokinetic study of a combination of beta adrenoreceptor antagonists - in the isolated perfused ovine eye

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Topically applied pilocarpine. Human pupillary response as a function of drop size

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Pharmacokinetics of topically applied ophthalmic drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Reduction in drop size of ophthalmic topical drop preparations and the impact of treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Binding of betaxolol, metoprolol and oligonucleotides to synthetic and bovine ocular melanin, and prediction of drug binding to melanin in human choroid-retinal pigment epithelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Timolol maleate: efficacy and safety

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Oral propranolol for exudative retinal detachment in diffuse choroidal hemangioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Oral propranolol for treatment of periocular infantile hemangiomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with wet age-related macular degeneration treated by bevacizumab

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

Rate limiting barrier to the penetration of ocular hypotensive beta blockers across the corneal epithelium in the pigmented rabbit.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108

inferred from DOI database lookup

7 January 2021

based on heuristic

Ocular Bioavailability and Systemic Loss of Topically Applied Ophthalmic Drugs

1 reference

https://api.crossref.org/works/10.1038%2FPR.2014.108